Japanese rapid/living recommendations on drug management for COVID‐19: updated guidelines (September 2021)-Reference-Cited by-同舟云学术

Japanese rapid/living recommendations on drug management for COVID‐19: updated guidelines (September 2021)

Published:2021-01 Issue:1 Volume:8 Page:
ISSN:2052-8817
Container-title:Acute Medicine & Surgery
language:en
Short-container-title:Acute Medicine & Surgery

Author:

Yamakawa Kazuma¹^ORCID,Yamamoto Ryo²,Terayama Takero³,Hashimoto Hideki⁴,Ishihara Tadashi⁵,Ishimaru Go⁶,Imura Haruki⁷,Okano Hiromu⁸^ORCID,Narita Chihiro⁹^ORCID,Mayumi Takuya¹⁰,Yasuda Hideto¹¹^ORCID,Yamada Kohei¹²,Yamada Hiroyuki¹³^ORCID,Kawasaki Tatsuya¹⁴,Shime Nobuaki¹⁵,Doi Kent¹⁶,Egi Moritoki¹⁷,Ogura Hiroshi¹⁸,Aihara Morio¹⁹,Kushimoto Shigeki²⁰^ORCID,Nishida Osamu²¹,

Affiliation:

1. Department of Emergency Medicine Osaka Medical and Pharmaceutical University Takatsuki Japan

2. Department of Emergency and Critical Care Medicine Keio University School of Medicine Tokyo Japan

3. Department of Psychiatry School of Medicine National Defense Medical College Tokorozawa Japan

4. Department of Infectious Diseases The University of Tokyo Hospital Tokyo Japan

5. Department of Emergency and Critical Care Medicine Juntendo University Urayasu Hospital Urayasu Japan

6. Department of General Internal Medicine Soka Municipal Hospital Soka Japan

7. Department of Infectious Diseases Rakuwakai Otowa Hospital/Department of Health Informatics School of Public Health Kyoto University Kyoto Japan

8. Department of Critical Care and Emergency Medicine National Hospital Organization Yokohama Medical Center Yokohama Japan

9. Department of Emergency Medicine and Intensive Care Medicine Shizuoka General Hospital Shizuoka Japan

10. Department of Internal Medicine Kanazawa Municipal Hospital Kanazawa Japan

11. Department of Emergency and Critical Care Medicine Jichi Medical University Saitama Medical Center Saitama Japan

12. Department of Traumatology and Critical Care Medicine National Defense Medical College Tokorozawa Japan

13. Department of Primary Care and Emergency Medicine Kyoto University Hospital Kyoto Japan

14. Department of Pediatric Critical Care Shizuoka Children's Hospital Shizuoka Japan

15. Department of Emergency and Critical Care Medicine Graduate School of Biomedical and Health Sciences Hiroshima University Hiroshima Japan

16. Department of Emergency and Critical Care Medicine The University of Tokyo Tokyo Japan

17. Division of Anesthesiology Department of Surgery Related Kobe University Graduate School of Medicine Kobe Japan

18. Department of Traumatology and Acute Critical Medicine Osaka University Medical School Suita Japan

19. Department of Gastroenterology and Hematology Hirosaki University Graduate School of Medicine Hirosaki Japan

20. Division of Emergency and Critical Care Medicine Tohoku University Graduate School of Medicine Sendai Japan

21. Department of Anesthesiology and Critical Care Medicine Fujita Health University School of Medicine Toyoake Japan

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ams2.706

Reference45 articles.

1. Japanese rapid/living recommendations on drug management for COVID‐19

2. Development of rapid guidelines: 3. GIN-McMaster Guideline Development Checklist extension for rapid recommendations

3. RoB 2: a revised tool for assessing risk of bias in randomised trials

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic interventions and the length of hospital stay for pediatric patients with COVID-19: a multicenter cohort study;Scientific Reports;2023-12-05

2. Intravenous methylprednisolone pulse therapy and the risk of in-hospital mortality among acute COVID-19 patients: Nationwide clinical cohort study;Critical Care;2023-02-08

3. Two Years of Experience and Methodology of Korean COVID-19 Living Clinical Practice Guideline Development;Journal of Korean Medical Science;2023

4. Phoenix or ghost: between science and emotion;Journal of the Japanese Society of Intensive Care Medicine;2022-11-01

5. Collaboration between generalist and ENT physicians in COVID-19 Omicron variant-induced laryngitis;Auris Nasus Larynx;2022-10